According to Gram Research analysis, hydroxysafflor yellow A, a natural compound from safflower plants, significantly reduced liver damage and improved blood flow in rats with fatty liver disease by deactivating harmful cellular pathways. The compound lowered liver damage markers by substantial amounts and widened blood vessels, allowing blood to flow more freely. However, this research is preliminary and only tested in animals, so human studies are needed before this treatment could be used in patients.
Researchers discovered that hydroxysafflor yellow A, a natural compound found in safflower plants, may help protect the liver and improve blood flow in people with metabolic-associated fatty liver disease (MAFLD). In a study using rats, the compound reduced liver damage, decreased inflammation, and improved how blood moves through tiny blood vessels. The research suggests this plant extract works by turning off overactive cellular signals that damage the liver. These findings could lead to new natural treatments for fatty liver disease, a condition affecting millions of people worldwide.
Key Statistics
A 2026 animal study published in Naunyn-Schmiedeberg’s archives of pharmacology found that hydroxysafflor yellow A treatment significantly reduced liver damage markers ALT and AST in rats with metabolic-associated fatty liver disease compared to untreated controls.
Rats treated with hydroxysafflor yellow A showed expanded mesenteric microvascular diameter and accelerated blood flow velocity, indicating improved circulation in tiny blood vessels affected by fatty liver disease.
The compound increased nitric oxide levels while decreasing endothelin-1 levels in treated rats, restoring the balance of substances that control blood vessel function in fatty liver disease.
The Quick Take
- What they studied: Whether a natural plant compound called hydroxysafflor yellow A could help treat fatty liver disease by improving blood flow in the liver
- Who participated: Laboratory rats that were given a special diet to develop fatty liver disease similar to the human condition
- Key finding: Rats treated with hydroxysafflor yellow A showed significant improvements in liver damage markers, better blood vessel function, and reduced inflammation compared to untreated rats
- What it means for you: This research is early stage and only tested in animals, so it cannot yet be applied to humans. However, it suggests a natural compound may eventually help treat fatty liver disease. Talk to your doctor before trying any new supplements, as more human studies are needed first
The Research Details
Scientists created fatty liver disease in laboratory rats using a special diet lacking certain nutrients. They then gave some rats hydroxysafflor yellow A, a natural compound extracted from safflower plants, while other rats received no treatment. The researchers measured liver damage markers in the blood, examined liver tissue under a microscope, and tested how well blood flowed through tiny blood vessels in the intestines. They also studied which genes and proteins were activated in the liver to understand how the compound worked.
This type of study is called a preclinical animal model study. It helps researchers understand whether a potential treatment is worth testing in humans. Animal studies are important because they allow scientists to control all the conditions and measure effects that would be difficult or impossible to measure in people. However, results in animals do not always translate to humans, so additional research is always needed.
The researchers focused on a specific pathway in cells called the EGFR/MAPK1 pathway, which they suspected was overactive in fatty liver disease. They measured whether hydroxysafflor yellow A could calm down this pathway and restore normal liver function.
Fatty liver disease is becoming increasingly common worldwide and can lead to serious liver damage if left untreated. Current treatment options are limited, so researchers are searching for new approaches. This study is important because it identifies a specific mechanism by which a natural compound might work, rather than just showing that it has an effect. Understanding the mechanism helps scientists develop better treatments and predict which patients might benefit most.
This is a laboratory animal study, which means it has both strengths and limitations. Strengths include careful control of all variables and the ability to measure detailed cellular changes. Limitations include that results in rats do not always apply to humans, and the study did not include a comparison group receiving standard treatments. The research was published in a peer-reviewed scientific journal, meaning other experts reviewed it before publication. However, animal studies are considered early-stage evidence and must be followed by human clinical trials before any treatment can be recommended for patients
What the Results Show
Rats treated with hydroxysafflor yellow A showed dramatic improvements in multiple measures of liver health. Blood tests showed significant reductions in liver damage markers called ALT and AST, which indicate how much liver injury is occurring. Cholesterol and triglyceride levels also decreased substantially, suggesting the compound improved fat metabolism in the liver.
The most interesting finding involved blood flow in tiny blood vessels. Researchers measured the diameter of small blood vessels in the intestines and found that treated rats had wider vessels and faster blood flow compared to untreated rats. This is important because poor blood flow contributes to liver damage in fatty liver disease. The compound also increased levels of a substance called nitric oxide, which helps blood vessels relax and function properly.
When scientists examined liver tissue under a microscope, they found that treated rats had less fat accumulation in liver cells and less inflammation. The liver tissue looked healthier overall compared to untreated rats. These improvements occurred because the compound reduced activity of specific proteins involved in inflammation and cell damage.
The research also measured a substance called endothelin-1, which causes blood vessels to constrict and can worsen liver disease. Treated rats had significantly lower levels of this harmful substance. Additionally, the compound reduced expression of a protein called VEGF, which is involved in abnormal blood vessel growth that occurs in liver disease. These secondary findings support the main mechanism by which hydroxysafflor yellow A appears to work: by calming overactive cellular signaling pathways and restoring normal blood vessel function.
This research builds on previous studies showing that hydroxysafflor yellow A has anti-inflammatory and antioxidant properties. Earlier research demonstrated the compound could improve blood flow in other conditions, but this is among the first studies specifically examining its effects on fatty liver disease and the EGFR/MAPK1 pathway. The findings align with current understanding that microcirculatory dysfunction, or poor blood flow in tiny vessels, plays a key role in fatty liver disease progression. This study provides a more detailed explanation of how the compound might address this problem.
This study has several important limitations. First, it was conducted only in laboratory rats, not humans, so results may not apply to people. Second, the study did not compare hydroxysafflor yellow A to standard treatments for fatty liver disease, so we do not know if it works better, worse, or the same as existing options. Third, the sample size and specific dosing details were not clearly reported in the abstract. Fourth, the study examined only one type of fatty liver disease model in rats, so results might differ in other disease variations. Finally, this is a single study, and results need to be confirmed by other independent research groups before any clinical recommendations can be made
The Bottom Line
At this stage, hydroxysafflor yellow A cannot be recommended as a treatment for fatty liver disease in humans because only animal studies have been completed. The evidence is preliminary and promising but not yet sufficient for clinical use. If you have fatty liver disease, work with your doctor on proven approaches including weight loss, reducing sugar intake, limiting alcohol, and increasing physical activity. Do not start taking hydroxysafflor yellow A supplements without consulting your healthcare provider, as safety and effectiveness in humans remain unknown
This research is most relevant to scientists and pharmaceutical companies developing new treatments for fatty liver disease. People with metabolic-associated fatty liver disease or those at risk for it should be aware of this emerging research but should not expect it to be available as a treatment soon. Healthcare providers treating liver disease may find this research interesting as it points toward potential future therapies. The general public should view this as early-stage research that may eventually lead to new treatments
This research is in the very early stages of development. Typically, a compound showing promise in animal studies requires 5 to 10 years of additional research, including human clinical trials, before it could potentially become an approved treatment. Even if human trials begin soon, it would likely be several years before hydroxysafflor yellow A could be available as a medical treatment. In the meantime, people with fatty liver disease should focus on proven lifestyle modifications
Frequently Asked Questions
Can I take hydroxysafflor yellow A to treat my fatty liver disease?
Not yet. This compound has only been tested in laboratory rats, not humans. No human clinical trials have been completed, so safety and effectiveness in people remain unknown. Talk to your doctor about proven treatments like weight loss, dietary changes, and exercise
How does hydroxysafflor yellow A help fatty liver disease?
The compound appears to work by turning off overactive cellular signals called the EGFR/MAPK1 pathway that contribute to liver damage. It also improves blood flow in tiny blood vessels and reduces inflammation in liver tissue
When will hydroxysafflor yellow A be available as a treatment?
This research is in very early stages. Even if human trials begin soon, it typically takes 5 to 10 years of additional research before a compound could become an approved medical treatment. No timeline for human testing has been announced
Is hydroxysafflor yellow A safe to take as a supplement?
Safety in humans has not been established through clinical trials. While the compound comes from a plant used in traditional medicine, this does not guarantee safety or effectiveness. Always consult your doctor before starting any new supplement
What should I do now if I have fatty liver disease?
Focus on proven approaches: lose weight if overweight, reduce sugar and refined carbohydrates, limit alcohol, increase physical activity, and work closely with your healthcare provider. These lifestyle changes have strong evidence for improving fatty liver disease
Want to Apply This Research?
- Track liver health markers by recording any blood test results for ALT and AST levels, cholesterol, and triglycerides every 3 to 6 months. Note the date of each test and the values to monitor trends over time
- Use the app to log daily habits that support liver health: minutes of physical activity, servings of vegetables, sugar intake, and alcohol consumption. Set weekly goals for each category and track progress
- Create a long-term dashboard showing trends in liver health markers over months and years. Set reminders for regular doctor visits and blood tests. Log any supplements or herbal products you take to discuss with your healthcare provider, including any future hydroxysafflor yellow A products if they become available
This article discusses preliminary research conducted in laboratory animals. Hydroxysafflor yellow A has not been tested in humans and is not approved by the FDA or any regulatory agency for treating fatty liver disease or any other condition. The findings cannot be applied to human treatment at this time. If you have fatty liver disease or any liver condition, consult with a qualified healthcare provider before making any changes to your treatment plan or starting any supplements. Do not use this information to self-diagnose or self-treat any medical condition. This article is for educational purposes only and should not be considered medical advice
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.